Form 4 for PCRX Pacira BioSciences, Inc.

Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-14 · accession 0001209191-23-038032 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-06-16	2023-06-14	PCRX	Williams Kristen Marie	Chief Administrative Off	A - Grant	$0.00	+10.9K	31.8K	+52%	$0
D	2023-06-16	2023-06-14	PCRX	Williams Kristen Marie	Chief Administrative Off	S - Sale	$37.03	-6,467	25.4K	-20%	-$239.5K
D	2023-06-16	2023-06-14	PCRX	Williams Kristen Marie	Chief Administrative Off	A - Grant	$0.00	+27.5K	27.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-06-14	A	A	10,950	$0.00	31,842	D	—	—	(F1) Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
2	Common	Common Stock	2023-06-14	S	D	6,467	$37.03	25,375	D	—	—
3	Derivative	Stock Option (Right to Buy)	2023-06-14	A	A	27,500	$0.00	27,500	D	$38.74 · — to 2033-06-14	27,500 Common Stock	(F3) The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.